Genus/£GNS
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Genus
Genus PLC, trading under the ticker GNS on the London Stock Exchange, specializes in animal genetics and biotechnology. The company, founded in 1994 and headquartered in Basingstoke, United Kingdom, operates across multiple countries offering genetically superior pig and cattle breeding stock along with state-of-the-art in vitro fertilization products. Genus PLC aims to empower customers in the livestock sector to enhance the efficiency and profitability of their operations by providing innovative genetic solutions and services.
Ticker
£GNS
Sector
Primary listing
LSE
Industry
Biotechnology
Headquarters
Employees
3,500
ISIN
GB0002074580
Website
Genus Metrics
BasicAdvanced
£1.3B
-
-£0.06
0.48
£0.32
1.65%
Price and volume
Market cap
£1.3B
Beta
0.48
52-week high
£21.60
52-week low
£14.24
Average daily volume
178K
Dividend rate
£0.32
Financial strength
Current ratio
1.939
Quick ratio
1.257
Long term debt to equity
54.357
Total debt to equity
57.63
Interest coverage (TTM)
3.26%
Profitability
EBITDA (TTM)
75
Gross margin (TTM)
38.43%
Net profit margin (TTM)
-0.60%
Operating margin (TTM)
9.26%
Effective tax rate (TTM)
-16.36%
Revenue per employee (TTM)
£190,000
Management effectiveness
Return on assets (TTM)
3.81%
Return on equity (TTM)
-1.18%
Valuation
Price to revenue (TTM)
1.894
Price to book
2.46
Price to tangible book (TTM)
3.67
Price to free cash flow (TTM)
40.641
Free cash flow yield (TTM)
2.46%
Free cash flow per share (TTM)
47.59%
Dividend yield (TTM)
1.65%
Growth
Revenue change (TTM)
-0.22%
Earnings per share change (TTM)
-112.14%
3-year revenue growth (CAGR)
5.63%
10-year revenue growth (CAGR)
5.61%
3-year earnings per share growth (CAGR)
-52.20%
10-year earnings per share growth (CAGR)
-19.27%
10-year dividend per share growth (CAGR)
5.75%
What the Analysts think about Genus
Analyst ratings (Buy, Hold, Sell) for Genus stock.
Bulls say / Bears say
Genus plc received FDA approval for its PRRS Resistant Pig (PRP) gene edit, potentially opening significant revenue streams in the U.S. market. (reuters.com)
The company has initiated a value acceleration program in its bovine business, targeting £10 million in annual cost savings, which could enhance profitability. (investing.com)
Genus's PIC segment achieved growth in royalty revenues and operating profit in North America, Europe, and Latin America, indicating strong market demand. (webull.com)
Genus reported a 5% decrease in revenue and a 31% decrease in adjusted profit before tax in its interim results, reflecting financial challenges. (investing.com)
The company's shares reached a new 52-week low in January 2025, indicating potential investor concerns about its performance. (marketbeat.com)
Genus's operations in China faced challenges, with a 50% profit decline in PIC Asia, highlighting regional market difficulties. (webull.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.
Genus Financial Performance
Revenues and expenses
Genus Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Genus stock?
Genus (GNS) has a market cap of £1.3B as of June 20, 2025.
What is the P/E ratio for Genus stock?
The price to earnings (P/E) ratio for Genus (GNS) stock is 0 as of June 20, 2025.
Does Genus stock pay dividends?
Yes, the Genus (GNS) stock pays dividends to shareholders. As of June 20, 2025, the dividend rate is £0.32 and the yield is 1.65%. Genus has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Genus dividend payment date?
The next Genus (GNS) dividend payment date is unconfirmed.
What is the beta indicator for Genus?
Genus (GNS) has a beta rating of 0.48. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.